Germany's pharma industry IT recruitment activity rises 9.5% in March 2022
Germany’s pharma industry registered a 9.5% rises in IT hiring activity in March 2022, according to GlobalData
Stay updated with breaking news from Cellular Immune. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Germany’s pharma industry registered a 9.5% rises in IT hiring activity in March 2022, according to GlobalData
Australia’s pharma industry registered a 3.3% rises in IT hiring activity in March 2022, according to GlobalData
Methodology:The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalDataâs Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, ...
Methodology:The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalDataâs Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, ...
Methodology:The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalDataâs Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, ...